Skip to main content

Peer Review reports

From: Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

Original Submission
2 Aug 2012 Submitted Original manuscript
29 Aug 2012 Reviewed Reviewer Report - Norio Akuta
31 Aug 2012 Reviewed Reviewer Report - Akihito Tsubota
26 Sep 2012 Author responded Author comments - Hidenori Toyoda
Resubmission - Version 2
26 Sep 2012 Submitted Manuscript version 2
16 Oct 2012 Author responded Author comments - Hidenori Toyoda
Resubmission - Version 3
16 Oct 2012 Submitted Manuscript version 3
26 Oct 2012 Author responded Author comments - Hidenori Toyoda
Resubmission - Version 4
26 Oct 2012 Submitted Manuscript version 4
Publishing
17 Nov 2012 Editorially accepted
27 Nov 2012 Article published 10.1186/1471-2334-12-324

You can find further information about peer review here.

Back to article page